Live financial reporting from established publishers, organized by market, company, sector, and region.
SBI Securities has picked 11 stocks for Samvat 2083, with up to 22% upside potential. The list spans steel, hospitality, jewellery, electronics and infrastructure.
Live, attributed financial reporting from established publishers.
Jio Platforms has unveiled an impressive 14% net profit growth to ₹8,387 crore for the September quarter, achieving a milestone subscriber count of 542 million, which includes 300 million utilizing 5G services. Revenue from operations climbed to ₹40,475 crore, fueled by a surge in digital services and a boost in average revenue per user, now at ₹218.8.
Sun Pharmaceutical has seen a notable 36% drop in net profit, juxtaposed with an 11.8% rise in consolidated revenue. The uplift in revenue can be attributed largely to strong sales growth in India and emerging markets, particularly in domestic formulations. Conversely, US formulation sales faced a significant downturn. The company also marked progress in its integration planning for the acquisition of Organon, following the successful completion of regulatory approvals.
Sun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Revenue grew 11.8%, supported by strong domestic and emerging market sales, while US formulations weakened.
Wall Street experienced significant losses as the Nasdaq fell to its lowest level in nearly three months. Concerns about rising capital expenditures at Amazon and cash burn warnings from Intel influenced the technology sector's downturn. Major technology stocks like Alphabet and Nvidia also saw notable declines due to investor scrutiny. Defensive sectors like consumer staples and healthcare gained some traction in response to the selloff.